Have your say: how can cancer care be improved?
If you would like to share your views on how cancer care could be improved, Cancer52 would like to hear from you.
News
Research and clinical trials
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Would you like to learn more about new and future treatments?
Our Education and Training Manager, Helen Mee, talks about our upcoming event in Glasgow and explains why you should join us
Which antibody to use first-line for follicular lymphoma?
Should obinutuzumab be used as part of the first-line treatment of follicular lymphoma or should we stick with rituximab?
Blog from BSH: Do people with Hodgkin lymphoma need irradiated blood forever?
Our Senior Medical Writer, Dr Becky Salisbury, talks about some of the hot topics raised at the recent British Society of Haematology meeting.
Blog from BSH: Do people with Hodgkin lymphoma need irradiated blood forever?
Our Senior Medical Writer, Dr Becky Salisbury, talks about some of the hot topics raised at the recent British Society of Haematology meeting.
Hu5F9-G4 clinical trial update
Promising results for new antibody treatment for B-cell lymphomas in ongoing Hu5F9-G4 clinical trial
Have you been affected by peripheral T-cell lymphoma?
Lymphoma Canada is seeking the views of peripheral T-cell lymphoma patients who have experience of pralatrexate or belinostat.
Living with mycosis fungoides?
Share your experiences in new study from Opinion Health, a UK healthcare research firm.
Have you been treated with CAR-T Cell therapy for DLBCL?
Lymphoma Canada is seeking the views of DLBCL patients who have had CAR-T Cell therapy.
New approaches show promise for high-grade non-Hodgkin lymphoma
Becky, our senior medical writer, looks at new approaches for high-grade non-Hodgkin lymphoma, discussed at the ASH meeting in December.